Advances in oral nano-delivery systems for colon targeted drug delivery in inflammatory bowel disease: selective targeting to diseased versus healthy tissue.

- Hua, Susan, Marks, Ellen, Schneider, Jennifer J., Keely, Simon

Ex vivo intestinal sacs to assess mucosal permeability in models of gastrointestinal disease

- Mateer, Sean W., Cardona, Jocelle, Marks, Ellen, Goggin, Bridie J., Hua, Susan, Keely, Simon

IL-6 drives neutrophil-mediated pulmonary inflammation associated with bacteremia in murine models of colitis

- Mateer, Sean W., Mathe, Andrea, Kim, Richard Y., Minahan, Kyra, Walker, Marjorie M., Callister, Robert C., Foster, Paul S., Horvat, Jay C., Hansbro, Philip M., Keely, Simon, Bruce, Jessica, Liu, Gang, Maltby, Steven, Fricker, Michael, Goggins, Bridie J., Tay, Hock L., Marks, Ellen, Burns, Grace

Immune dysregulation in the functional gastrointestinal disorders

- Keely, Simon, Walker, Marjorie M., Marks, Ellen, Talley, Nicholas J.

Oral delivery of prolyl hydroxylase inhibitor: AKB-4924 promotes localized mucosal healing in a mouse model of colitis

- Marks, Ellen, Goggins, Bridie J., Cardona, Jocelle, Cole, Siobhan, Minahan, Kyra, Mateer, Sean, Walker, Marjorie M., Shalwitz, Robert, Keely, Simon

Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease

- Mateer, Sean W., Maltby, Steven, Marks, Ellen, Foster, Paul S., Horvat, Jay C., Hansbro, Philip M., Keely, Simon

Potential mechanisms regulating pulmonary pathology in inflammatory bowel disease

- Mateer, Sean W., Maltby, Steven, Marks, Ellen, Foster, Paul S., Horvat, Jay C., Hansbro, Philip M., Keely, Simon